Reliability and validity of the Turkish version of lumbar stiffness disability index
Acta Orthopaedica et Traumatologica Turcica · 2024
DOI: 10.5152/j.aott.2024.23190 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Acta Orthopaedica et Traumatologica Turcica, 2024. Verfasst von Aliekber Yapar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Traumatology, Antalya Training and Research Hospital, Antalya, Türkiye. Hauptthemen laut MEDLINE: Disability Evaluation, Lumbar Vertebrae, Spinal Fusion. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
Post-lumbar fusion surgery often restricts daily activities due to lumbar stiffness. The validity and reliability of the lumbar stiffness disability index (LSDI) in Türkiye, which measures the impact of lumbar stiffness on functional abilities, have not yet been confirmed. This study aims to test the validity and reliability of the Turkish version of LSDI (Tr-LSDI).
Methods
Sixty-six patients who underwent lumbar fusion surgery were included in this methodological study. The Tr-LSDI was developed using a forward-backward translation. Using the Davis technique and expert feedback, we confirmed the content validity (CV) of the Tr-LSDI. The construct validity of the Tr-LSDI was assessed with exploratory factor analysis (EFA) and convergent validity. Convergent validity was examined by correlation analysis between Tr-LSDI, the Oswestry disability index (ODI) scores, and the number of fusion levels. Internal consistency was determined using Cronbach’s alpha coefficients, and test–retest reliability was assessed with the intraclass correlation coefficient (ICC).
Results
Expert evaluation yielded CV indexes > 0.8 for all items. Exploratory factor analysis revealed a one-factor structure for Tr-LSDI, comprising 10 items that accounted for 63.7% of the variance. Factor loadings spanned from 0.371 to 0.926. Notably, the Tr-LSDI score correlated with fusion levels (r=0.386, P=.001) and demonstrated a robust correlation with ODI (r=0.899, P < .001), affirming its convergent validity. The Tr-LSDI displayed excellent internal consistency with a Cronbach’s alpha coefficient of 0.934. The ICC was 0.980.
Conclusion
The Tr-LSDI is a validated, reliable tool for measuring lumbar stiffness in Türkiye. Its consistency, validity, and alignment with the original LSDI make it suitable for clinical and research use. Level of Evidence: Level II, Diagnostic Study. Cite this article as: Yapar A, Yapar D, Selçuk H, Faruk Kılıçaslan Ö, Faruk Eğerci Ö, Karataş Ö. Reliability and validity of the Turkish version of lumbar stiffness disability index. Acta Orthop Traumatol Turc., 2024;58(5):280-285.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics and Traumatology, Antalya Training and Research Hospital, Antalya, Türkiye.
- Department of Public Health, Turkish Ministry of Health, Muratpasa District Health Directorate, Antalya, Türkiye.
- Institute of Health Science, Medical Informatics, Akdeniz University, Antalya, Türkiye.
- Department of Physical Medicine and Rehabilitation, Akdeniz University Faculty of Medicine, Türkiye.
Zitieren
APA
Yapar, A., Yapar, D., Selçuk, H., Kılıçaslan, Ö. F., Eğerci, Ö. F., & Karataş, Ö. (2024). Reliability and validity of the Turkish version of lumbar stiffness disability index. Acta Orthopaedica et Traumatologica Turcica. https://doi.org/10.5152/j.aott.2024.23190
Vancouver
Yapar A, Yapar D, Selçuk H, Kılıçaslan ÖF, Eğerci ÖF, Karataş Ö. Reliability and validity of the Turkish version of lumbar stiffness disability index. Acta Orthopaedica et Traumatologica Turcica. 2024. doi:10.5152/j.aott.2024.23190
BibTeX
@article{Yapar2024,
author = {Yapar, Aliekber and Yapar, Dilek and Selçuk, Hüseyin and Kılıçaslan, Ömer Faruk and Eğerci, Ömer Faruk and Karataş, Özlem},
title = {Reliability and validity of the Turkish version of lumbar stiffness disability index},
journal = {Acta Orthopaedica et Traumatologica Turcica},
year = {2024},
doi = {10.5152/j.aott.2024.23190}
}
EUVIMED